+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

CAR-T Therapy Pipeline Analysis Global Market Opportunities and Strategies to 2030: COVID-19 Growth and Change

  • ID: 5440747
  • Report
  • September 2021
  • Region: Global
  • 234 Pages
  • The Business Research Company

FEATURED COMPANIES

  • Gilead Sciences
  • Novartis AG

CAR-T Therapy Pipeline Analysis Global Market Opportunities and Strategies To 2030: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global CAR-T therapy market as it emerges from the COVID 19 shut down.







Reasons to Purchase


  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis.

Description:

Where is the largest and fastest growing market for CAR-T therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The CAR-T therapy market global report from the publisher answers all these questions and many more.


The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider CAR-T therapy market, and compares it with other markets.



The report covers the following chapters


  • Executive Summary - The executive summary section of the report gives a brief overview and summary of the report.
  • Report Structure - This section gives the structure of the report and the information covered in the various sections.
  • Introduction - The introduction section of the report gives brief introduction about segmentation by geography and segmentation by target antigen and by application.
  • Market Characteristics - The market characteristics section of the report defines and explains the CAR-T therapy market. This chapter also defines and describes products covered in the report.
  • Customer Information - This chapter covers recent customers’ trends/preferences in the global CAR-T therapy market
  • Trends and Strategies - This chapter describes the major trends shaping the global CAR-T therapy market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • COVID Impact Analysis - This section provides an insight on how the pandemic is impacting the CAR-T therapy market.
  • Global Market Size and Growth - This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis - This section contains the historic (2015-2020) and forecast (2020-2025),and (2025-2030) market values and growth and market share comparison by region.
  • Segmentation - This section contains the market values (2015-2030) and analysis for different segments.
  • Regional Market Size and Growth - This section contains the region’s market size (2020), historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape - This section covers details on the competitive landscape of the global CAR-T therapy market, estimated market shares and company profiles for the leading players.
  • Pipeline Analysis - This chapter covers information about the drugs currently in pipeline
  • Key Mergers and Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Opportunities and Strategies - This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions and Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for CAR-T therapy companies in terms of product offerings, geographic expansion, price offerings, and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope


Markets Covered:



  1. By Target Antigen: CD19; CD22; BCMA; Others
  2. By Application: Acute Lymphoblastic Leukemia; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Chronic Lymphocytic Leukemia; Multiple Myeloma; Others

Companies Mentioned:

Gilead Sciences; Novartis AG


Metrics Covered:

Number of Enterprises; Number of Employees


Countries:

Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA


Regions:

Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa


Time series:

Five years historic and ten years forecast.


Data:

Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, CAR-T Therapy Pipeline Analysis Equipment indicators comparison.


Data segmentations:

Country and regional historic and forecast data, market share of competitors, market segments.


Sourcing and Referencing:

Data and analysis throughout the report is sourced using end notes.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Gilead Sciences
  • Novartis AG
1. CAR-T Therapy Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction
6.1. Segmentation By Geography
6.2. Segmentation By Target Antigen
6.3. Segmentation By Application

7. CAR-T Therapy Market Characteristics
7.1. Market Definition
7.2. Market Segmentation By Target Antigen
7.2.1. CD19 Therapy
7.2.2. CD22 Therapy
7.2.3. BCMA Therapy
7.2.4. Others
7.3. Market Segmentation By Application
7.3.1. Acute Lymphoblastic Leukemia
7.3.2. Diffuse Large B-Cell Lymphoma
7.3.3. Follicular Lymphoma
7.3.4. Chronic Lymphocytic Leukemia
7.3.5. Multiple Myeloma
7.3.6. Others

8. CAR-T Therapy Market, COVID Impact Analysis
8.1. Impact On Global CAR-T Therapy
8.2. Impact On Global CAR-T Therapy Clinical Trials
8.3. Impact On People Undergoing CAR-T Therapy
8.4. Impact On Leading Global Oncology Companies
8.5. Future Outlook

9. CAR-T Therapy Market Trends and Strategies
9.1. Remodeled CAR-T Cell Therapy For Fewer Side Effects
9.2. Off-The-Shelf Allogeneic CAR-T Therapy For Improved Treatment
9.3. Next-Generation CAR-T Cells For Treatment Of High-Grade Glioma
9.4. Machine Learning and Artificial Intelligence To Optimize Future CAR-T Therapy
9.5. Collaborating With Technology Companies For Advanced Technologies
9.6. Growing Partnerships For Promoting CAR-T Therapy Market

10. Global CAR-T Therapy Market Size and Growth
10.1. Market Size
10.2. Historic Market Growth, 2015 - 2020, Value ($ Million)
10.2.1. Drivers Of The Market 2015 - 2020
10.2.2. Restraints On The Market 2015 - 2020
10.3. Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
10.3.1. Drivers Of The Market 2020 - 2025
10.3.2. Restraints On The Market 2020 - 2025

11. Global CAR-T Therapy Market Segmentation
11.1. Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
11.1.1. CD19
11.1.2. CD22
11.1.3. BCMA
11.2. Global CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
11.2.1. Diffuse Large B-Cell Lymphoma
11.2.2. Acute Lymphoblastic Leukemia
11.2.3. Follicular Lymphoma
11.2.4. Multiple Myeloma

12. CAR-T Therapy Market, Regional and Country Analysis
12.1. Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
12.2. Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

13. Asia-Pacific CAR-T Therapy Market
13.1. Asia-Pacific CAR-T Therapy Market Overview
13.1.1. Region Information
13.1.2. Market Information
13.1.3. Impact of COVID-19
13.1.4. Background Information
13.1.5. Government Initiatives
13.1.6. Regulations
13.1.7. Regulatory Bodies
13.1.8. Major Associations
13.1.9. Taxes Levied
13.1.10. Corporate Tax Structure
13.1.11. Investment
13.1.12. Major Companies
13.2. Asia-Pacific CAR-T Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.3. Asia-Pacific CAR-T Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.4. Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.5. Asia-Pacific CAR-T Therapy Market: Country Analysis
13.6. China CAR-T Therapy Market
13.7. China CAR-T Therapy Market Overview
13.7.1. Country Information
13.7.2. Market Information
13.7.3. Impact of COVID-19
13.7.4. Background Information
13.7.5. Government Initiatives
13.7.6. Regulations
13.7.7. Regulatory Bodies
13.7.8. Major Associations
13.7.9. Taxes Levied
13.7.10. Corporate Tax Structure
13.7.11. Investment
13.7.12. Major Companies
13.8. China CAR-T Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.9. China CAR-T Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.10. China CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.11. India CAR-T Therapy Market
13.12. India CAR-T Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.13. India CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.14. Japan CAR-T Therapy Market
13.15. Japan CAR-T Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.16. Japan CAR-T Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.17. Japan CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.18. Australia CAR-T Therapy Market
13.19. Australia CAR-T Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.20. Australia CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.21. Indonesia CAR-T Therapy Market
13.22. Indonesia CAR-T Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.23. Indonesia CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.24. South Korea CAR-T Therapy Market
13.25. South Korea CAR-T Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.26. South Korea CAR-T Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.27. South Korea CAR-T Therapy Market, Segmentation By Application , Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

14. Western Europe CAR-T Therapy Market
14.1. Western Europe CAR-T Therapy Market Overview
14.1.1. Region Information
14.1.2. Market Information
14.1.3. Impact of COVID-19
14.1.4. Background Information
14.1.5. Government Initiatives
14.1.6. Regulations
14.1.7. Regulatory Bodies
14.1.8. Major Associations
14.1.9. Taxes Levied
14.1.10. Corporate Tax Structure
14.1.11. Investments
14.1.12. Major Companies
14.2. Western Europe CAR-T Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.3. Western Europe CAR-T Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.4. Western Europe CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.5. Western Europe CAR-T Therapy Market: Country Analysis
14.6. UK CAR-T Therapy Market
14.7. UK CAR-T Therapy Market Overview
14.7.1. Country Information
14.7.2. Market Information
14.7.3. Impact of COVID-19
14.7.4. Background Information
14.7.5. Government Initiatives
14.7.6. Regulations
14.7.7. Regulatory Bodies
14.7.8. Associations
14.7.9. Taxes Levied
14.7.10. Corporate Tax Structure
14.7.11. Investments
14.7.12. Major Companies
14.8. UK CAR-T Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.9. UK CAR-T Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.10. UK CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.11. Germany CAR-T Therapy Market
14.12. Germany CAR-T Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.13. Germany CAR-T Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.14. Germany CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.15. France CAR-T Therapy Market
14.16. France CAR-T Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.17. France CAR-T Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.18. France CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

15. Eastern Europe CAR-T Therapy Market
15.1. Eastern Europe CAR-T Therapy Market Overview
15.1.1. Region Information
15.1.2. Market Information
15.1.3. Impact of COVID-19
15.1.4. Background Information
15.1.5. Government Initiatives
15.1.6. Regulations
15.1.7. Regulatory Bodies
15.1.8. Associations
15.1.9. Taxes Levied
15.1.10. Corporate Tax Structure
15.1.11. Investments
15.1.12. Major Companies
15.2. Eastern Europe CAR-T Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
15.3. Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.4. Eastern Europe CAR-T Therapy Market: Country Analysis
15.5. Russia CAR-T Therapy Market
15.6. Russia CAR-T Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
15.7. Russia CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

16. North America CAR-T Therapy Market
16.1. North America CAR-T Therapy Market Overview
16.1.1. Region Information
16.1.2. Market Information
16.1.3. Impact Of COVID-19
16.1.4. Background Information
16.1.5. Government Initiatives
16.1.6. Regulations
16.1.7. Regulatory Bodies
16.1.8. Major Associations
16.1.9. Taxes Levied
16.1.10. Corporate Tax Structure
16.1.11. Investments
16.1.12. Major Companies
16.2. North America CAR-T Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
16.3. North America CAR-T Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
16.4. North America CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16.5. North America CAR-T Therapy Market: Country Analysis
16.6. USA CAR-T Therapy Market
16.7. USA CAR-T Therapy Market Overview
16.7.1. Country Information
16.7.2. Impact Of COVID-19
16.7.3. Market Information
16.7.4. Background Information
16.7.5. Government Initiatives
16.7.6. Regulations
16.7.7. Regulatory Bodies
16.7.8. Major Associations
16.7.9. Corporate Tax Structure
16.7.10. Investments
16.7.11. Major Companies
16.8. USA CAR-T Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
16.9. USA CAR-T Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
16.10. USA CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

17. South America CAR-T Therapy Market
17.1. South America CAR-T Therapy Market Overview
17.1.1. Region Information
17.1.2. Market Information
17.1.3. COVID Impact
17.1.4. Background Information
17.1.5. Government Initiatives
17.1.6. Regulations
17.1.7. Regulatory Bodies
17.1.8. Major Associations
17.1.9. Taxes Levied
17.1.10. Corporate Tax Structure
17.1.11. Investments
17.1.12. Major Companies
17.2. South America CAR-T Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
17.3. South America CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
17.4. South America CAR-T Therapy Market: Country Analysis
17.5. Brazil CAR-T Therapy Market
17.6. Brazil CAR-T Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
17.7. Brazil CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

18. Middle East CAR-T Therapy Market
18.1. Middle East CAR-T Therapy Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. Impact of COVID-19
18.1.4. Background Information
18.1.5. Government Initiatives
18.1.6. Regulations
18.1.7. Regulatory Bodies
18.1.8. Major Associations
18.1.9. Investments
18.1.10. Taxes Levied
18.1.11. Corporate Tax Structure
18.1.12. Major Companies
18.2. Middle East CAR-T Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
18.3. Middle East CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

19. Africa CAR-T Therapy Market
19.1. Africa CAR-T Therapy Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. Impact Of COVID-19
19.1.4. Background Information
19.1.5. Government Initiatives
19.1.6. Regulations
19.1.7. Regulatory Bodies
19.1.8. Major Associations
19.1.9. Investments
19.1.10. Taxes Levied
19.1.11. Corporate Tax Structure
19.1.12. Major Companies
19.2. Africa CAR-T Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
19.3. Africa CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

20. Global CAR-T Therapy Market Competitive Landscape
20.1. Company Profiles
20.2. Gilead Sciences
20.2.1. Company Overview
20.2.2. Products and Services
20.2.3. Business Strategy
20.2.4. Financial Overview
20.3. Novartis AG
20.3.1. Company Overview
20.3.2. Products and Services
20.3.3. Business Strategy
20.3.4. Financial Overview

21. CAR-T Therapy Pipeline Analysis
21.1. Comparison Of The Landscape Of Active Trials Of Cancer Cell Therapies In 2020
21.2. CAR T-Cell Therapy, Number Of Active Trials By Cancer Type
21.3. CAR T-Cell Therapy, Number Of Active Trials By Cancer Type
21.4. Global CAR-T Cell Therapy By Trial Site
21.5. Number of Molecules In Cancer Clinical Trails, By Target
21.6. CAR-T Cell Therapy Pipeline Analysis

22. Key Mergers and Acquisitions In The CAR-T Therapy Market
22.1. ResTORbio Merged With Adicet Bio
22.2. Astellas Pharma Acquired Xyphos Biosciences
22.3. Bristol Myers Squibb Acquired Celgene Corporation
22.4. Celgene Acquired Juno Therapeutics
22.5. Gilead Sciences Acquired Cell Design Labs
22.6. Gilead Sciences Acquired Kite Pharma

23. CAR-T Therapy Market Opportunities & Strategies
23.1. Global CAR-T Therapy Market In 2025 - Countries Offering Most New Opportunities
23.2. Global CAR-T Therapy Market In 2025 - Segments Offering Most New Opportunities
23.3. Global CAR-T Therapy Market In 2025 - Growth Strategies
23.3.1. Market Trend Based Strategies
23.3.2. Competitor Strategies

24. CAR-T Therapy Market, Conclusions and Recommendations
24.1. Conclusions
24.2. Recommendations
24.2.1. Product
24.2.2. Place
24.2.3. Price
24.2.4. Promotion
24.2.5. People

25. Appendix
25.1. Market Data Sources
25.2. Research Methodology
25.3. Currencies
25.4. Research Inquiries
25.5. About the Publisher
25.6. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Gilead Sciences
  • Novartis AG
The CAR-T therapy market consists of sales of CAR-T therapy products and related services by entities (organizations, sole traders and partnerships) that develop chimeric antigen receptor (CAR) T-cell therapies to treat all types of cancers. This industry includes establishments that are involved in the research and development to introduce new targeted cell therapies for treating different blood related cancers. It covers 2015 to 2020, termed the historic period, and 2020 to 2025 termed the forecast period, along with further forecasts for the period 2025-2030.

The global CAR-T therapy market reached a value of nearly $1,037 million in 2020. The market is expected to grow from $1,037.0 million in 2020 to $3,150.0 million in 2025 at a rate of 24.9%. The growth is mainly due to an increased prevalence of cancer and increased awareness about the therapy. The market is expected to stabilize $ 6,100 million in 2030.

Growth in the historic period resulted from increases in healthcare expenditure, increase in pharmaceutical R&D expenditure and advances in drug discovery. This growth was restricted by low rate of drug approvals, challenges due to regulatory changes and limited number of treatment centers.

Going forward, increase in blood cancer incidence rate, rise in healthcare expenditure, strong pipeline of drugs and rising focus on car-t therapy are expected to drive the market. High costs of therapy, reimbursement challenges, adverse events, complex manufacturing and supply chain and covid-19 impacting drug trails, and reduction in free trade are major factors that could hinder the growth of the CAR-T therapy market in the future.

The CAR-T therapy market is segmented by target antigen into CD19, CD22, BCMA and others. The CD19 was the largest segment of the CAR-T therapy market by target antigen, accounting for 100% of the total market in 2020. Going forward, CD19 segment is expected to be the fastest growing segment in the CAR-T therapy market, at a CAGR of 12.0%.

The CAR-T therapy market is also segmented by application into acute lymphoblastic leukemia, diffuse large B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia, multiple myeloma and others. The diffuse large B-cell lymphoma was the largest segment of the CAR-T therapy market by application, accounting for 54.0% of the total market in 2020. Going forward, the others segment is expected to be the fastest growing segment in the CAR-T therapy market, at a CAGR of 71.1%.

North America was the largest region in the global CAR-T therapy market, accounting for 56.1% of the total in 2020. It was followed by Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the CAR-T therapy market will be Asia Pacific and Western Europe, where growth will be at CAGRs of 53.8% and 23.3% respectively.

The CAR-T therapy market is particularly prone to disruption from the coronavirus outbreak, as patients with cancer are more susceptible to viral infections, especially after chemotherapy, stem cell transplants, or surgeries. COVID-19 has caused clinical trial delays for CAR-T therapy drugs. Due to worldwide lockdown, production is also being halted which is causing supply chain issues.

The CAR-T therapy market is concentrated, with a small number of large of large players in the market. Major players in the market include Novartis AG and Gilead Pharmaceuticals.

The top opportunities in the CAR-T therapy market segmented by target antigen will arise in the CD19 segment, which will gain $790.0 million of global annual sales by 2025. The top opportunities in the CAR-T therapy market segmented by application will arise in the diffuse large B-cell lymphoma segment, which will gain $850.0 million of global annual sales by 2023. The CAR-T therapy market size will gain the most in the USA at $803.4 million. Market-trend-based strategies for the CAR-T therapy market include focus efforts towards investing in the R&D for creating remodeled CAR-T therapy to avoid neurological side-effects, creating off-the-shelf allogeneic CAR-T therapy for advanced cancer treatment, manufacturing next-generation CAR T cells for improved treatment of high-grade glioma, investing in AI and machine learning solutions to optimize future CAR-T therapy, carrying out strategic collaborations to boost innovations, collaborating or acquiring competitor companies to expand CAR-T therapy portfolio, and investing in the CAR-T therapy to make it more effective. Player-adopted strategies in the CAR-T therapy market include expansion through mergers and acquisitions, and strategic partnerships with technology companies.

To take advantage of these opportunities, the publisher recommends the CAR-T therapy companies to focus on adoption of machine learning and artificial intelligence technologies, remodeled CAR-T cell therapy, expanding in countries offering advanced technologies, focus on developed markets, offer bundled payments, increase visibility through websites, focus on patient referral systems, focus on hospitals and other treatment centers among other strategies.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Gilead Sciences
  • Novartis AG
Note: Product cover images may vary from those shown

Loading
LOADING...